Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Prevalence of serum neutralizing antibody to serotype 9 rotavirus WI61 in children from South America and central Europe.

Literature DB >> 1847150

Prevalence of serum neutralizing antibody to serotype 9 rotavirus WI61 in children from South America and central Europe.

Abstract

Neutralizing serum antibody to serotype 9 rotavirus WI61 was detected in 41% of 870 Ecuadorian children and 26% of 140 German children. In both areas an age-related prevalence increase was observed. We identified 11 serum samples from Ecuadorian children which neutralized exclusively serotype 9 rotavirus. Thirteen of 71 (18%) German children hospitalized with serologically defined primary rotavirus gastroenteritis showed a seroconversion to serotype 9 rotavirus; however, in 10 of these 13 patients, the infecting serotype could be identified as serotype 1, 3, or 4. Furthermore, all 13 patients showed fourfold increases in titer to at least one further serotype.

Entities: Disease Species

Mesh：

Substances：
Antibodies, Viral

Year: 1991 PMID： 1847150 PMCID： PMC269732 DOI： 10.1128/jcm.29.1.208-211.1991

Source DB: PubMed Journal: J Clin Microbiol ISSN： 0095-1137 Impact factor: 5.948

17 in total

1. Direct serotyping of human rotavirus in stools by an enzyme-linked immunosorbent assay using serotype 1-, 2-, 3-, and 4-specific monoclonal antibodies to VP7.

Authors: K Taniguchi; T Urasawa; Y Morita; H B Greenberg; S Urasawa
Journal: J Infect Dis Date: 1987-06 Impact factor: 5.226

2. Comparative sensitivities of solid-phase immune electron microscopy and enzyme-linked immunosorbent assay for serotyping of human rotavirus strains with neutralizing monoclonal antibodies.

Authors: G Gerna; A Sarasini; B S Coulson; M Parea; M Torsellini; E Arbustini; M Battaglia
Journal: J Clin Microbiol Date: 1988-07 Impact factor: 5.948

3. A candidate for a new serotype of human rotavirus.

Authors: S Matsuno; A Hasegawa; A Mukoyama; S Inouye
Journal: J Virol Date: 1985-05 Impact factor: 5.103

4. Rotavirus isolate WI61 representing a presumptive new human serotype.

Authors: H F Clark; Y Hoshino; L M Bell; J Groff; G Hess; P Bachman; P A Offit
Journal: J Clin Microbiol Date: 1987-09 Impact factor: 5.948

5. Complete nucleotide sequence of the gene encoding VP4 of a human rotavirus (strain K8) which has unique VP4 neutralization epitopes.

Authors: K Taniguchi; K Nishikawa; T Urasawa; S Urasawa; K Midthun; A Z Kapikian; M Gorziglia
Journal: J Virol Date: 1989-09 Impact factor: 5.103

6. Prevalence of antibodies to rotavirus in different age-groups of infants in Bochum, West Germany.

Authors: H Brüssow; H Werchau; W Liedtke; L Lerner; C Mietens; J Sidoti; J Sotek
Journal: J Infect Dis Date: 1988-05 Impact factor: 5.226

7. Prevalent patterns of serotype-specific seroconversion in Mexican children infected with rotavirus.

Authors: F I Puerto; L Padilla-Noriega; A Zamora-Chávez; A Briceño; M Puerto; C F Arias
Journal: J Clin Microbiol Date: 1987-05 Impact factor: 5.948

8. Development of neutralizing antibodies and group A common antibodies against natural infections with human rotavirus.

Authors: B J Zheng; S X Han; Y K Yan; X R Liang; G Z Ma; Y Yang; M H Ng
Journal: J Clin Microbiol Date: 1988-08 Impact factor: 5.948

9. Comparison of immunoglobulin A (IgA), IgG, and IgM enzyme-linked immunosorbent assays, plaque reduction neutralization assay, and complement fixation in detecting seroresponses to rotavirus vaccine candidates.

Authors: K Midthun; L Z Pang; J Flores; A Z Kapikian
Journal: J Clin Microbiol Date: 1989-12 Impact factor: 5.948